T W LeBien - JoVE Visualize

Showing results (51-60 of 90) with videos related to

Pageof 9

Sort By:

Journal of the American Society of Nephrology : JASN|April 1, 1991

Biochemical and histochemical characterization of a murine tubular antigenI D Davis, T W LeBien, B J Lindman, et al.

Leukemia|February 24, 2001

Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cellsF E Bertrand, C E Eckfeldt, A S Lysholm, et al.

Leukemia Research|January 1, 1986

Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamid (ASTA Z 7557)T W LeBien, J M Anderson, D A Vallera, et al.

Molecular Immunology|October 1, 1985

p24 and p26, structurally related cell surface molecules identified by monoclonal antibody BA-2T W LeBien, S J Pirruccello, R T McCormack, et al.

Blood|December 1, 1982

Normal human pluripotential and committed hematopoietic progenitors do not express the p24 antigen detected by monoclonal antibody BA-2: implications for immunotherapy of lymphocytic leukemiaR C Ash, J Jansen, J H Kersey, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993

Functional effect of IL-7-enhanced CD19 expression on human B cell precursorsM L Wolf, W K Weng, K T Stieglbauer, et al.

Blood|September 15, 1990

Analysis of immunoglobulin and T-cell receptor gene rearrangements in human fetal bone marrow B lineage cellsT W LeBien, R L Elstrom, M Moseley, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998

Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cellsW K Weng, N Shah, D O'Brien, et al.

Cancer Research|August 15, 1995

Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6D Billadeau, D F Jelinek, N Shah, et al.

Cancer Research|June 1, 1997

Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6D Billadeau, P Liu, D Jelinek, et al.

Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:

Pageof 9

Journal of the American Society of Nephrology : JASN|April 1, 1991

Biochemical and histochemical characterization of a murine tubular antigenI D Davis, T W LeBien, B J Lindman, et al.

Leukemia|February 24, 2001

Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cellsF E Bertrand, C E Eckfeldt, A S Lysholm, et al.

Leukemia Research|January 1, 1986

Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamid (ASTA Z 7557)T W LeBien, J M Anderson, D A Vallera, et al.

Molecular Immunology|October 1, 1985

p24 and p26, structurally related cell surface molecules identified by monoclonal antibody BA-2T W LeBien, S J Pirruccello, R T McCormack, et al.

Blood|December 1, 1982

Normal human pluripotential and committed hematopoietic progenitors do not express the p24 antigen detected by monoclonal antibody BA-2: implications for immunotherapy of lymphocytic leukemiaR C Ash, J Jansen, J H Kersey, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993

Functional effect of IL-7-enhanced CD19 expression on human B cell precursorsM L Wolf, W K Weng, K T Stieglbauer, et al.

Blood|September 15, 1990

Analysis of immunoglobulin and T-cell receptor gene rearrangements in human fetal bone marrow B lineage cellsT W LeBien, R L Elstrom, M Moseley, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998

Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cellsW K Weng, N Shah, D O'Brien, et al.

Cancer Research|August 15, 1995

Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6D Billadeau, D F Jelinek, N Shah, et al.

Cancer Research|June 1, 1997

Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6D Billadeau, P Liu, D Jelinek, et al.

Pageof 9